TRIAZINE COMPOUNDS AS P13 KINASE AND MTOR INHIBITORS

TRIAZINE COMPOUNDS AS PI3 KINASE AND MTOR INHIBITORS Compounds of formula I wherein: R 1 is and R 2 , R 4 , and R 6-9 are defined herein, and pharmaceutically acceptable salts and esters thereof. These compounds inhibit PI3 kinase and mTOR, and may be used to treat diseases mediated by PI3 kinase an...

Full description

Saved in:
Bibliographic Details
Main Authors VENKATESAN, ARANAPAKAM, M, AYRAL-KALOUSTIAN, SEMIRAMIS, SHI, MENGXIAO, DELOS SANTOS, EFREN, GUILLERMO, GOPALSAMY, ARIAMALA, CURRAN, KEVIN, J, DOS SANTOS, OSVALDO, MANSOUR, TAREK, S, DEHNHARDT, CHRISTOPH, M, KAPLAN, JOSHUA, AARON, ZASK, ARIE, CHEN, ZECHENG, VERHEIJEN, JEROEN, C, RICHARD, DAVID, J
Format Patent
LanguageEnglish
Serbian
Published 28.06.2019
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract TRIAZINE COMPOUNDS AS PI3 KINASE AND MTOR INHIBITORS Compounds of formula I wherein: R 1 is and R 2 , R 4 , and R 6-9 are defined herein, and pharmaceutically acceptable salts and esters thereof. These compounds inhibit PI3 kinase and mTOR, and may be used to treat diseases mediated by PI3 kinase and mTOR, such as a variety of cancers. Methods for making and using the compounds of this invention are disclosed. Various compositions containing the compounds of this invention are also disclosed.
AbstractList TRIAZINE COMPOUNDS AS PI3 KINASE AND MTOR INHIBITORS Compounds of formula I wherein: R 1 is and R 2 , R 4 , and R 6-9 are defined herein, and pharmaceutically acceptable salts and esters thereof. These compounds inhibit PI3 kinase and mTOR, and may be used to treat diseases mediated by PI3 kinase and mTOR, such as a variety of cancers. Methods for making and using the compounds of this invention are disclosed. Various compositions containing the compounds of this invention are also disclosed.
Author DEHNHARDT, CHRISTOPH, M
CHEN, ZECHENG
AYRAL-KALOUSTIAN, SEMIRAMIS
MANSOUR, TAREK, S
SHI, MENGXIAO
DELOS SANTOS, EFREN, GUILLERMO
VENKATESAN, ARANAPAKAM, M
DOS SANTOS, OSVALDO
KAPLAN, JOSHUA, AARON
CURRAN, KEVIN, J
GOPALSAMY, ARIAMALA
RICHARD, DAVID, J
ZASK, ARIE
VERHEIJEN, JEROEN, C
Author_xml – fullname: VENKATESAN, ARANAPAKAM, M
– fullname: AYRAL-KALOUSTIAN, SEMIRAMIS
– fullname: SHI, MENGXIAO
– fullname: DELOS SANTOS, EFREN, GUILLERMO
– fullname: GOPALSAMY, ARIAMALA
– fullname: CURRAN, KEVIN, J
– fullname: DOS SANTOS, OSVALDO
– fullname: MANSOUR, TAREK, S
– fullname: DEHNHARDT, CHRISTOPH, M
– fullname: KAPLAN, JOSHUA, AARON
– fullname: ZASK, ARIE
– fullname: CHEN, ZECHENG
– fullname: VERHEIJEN, JEROEN, C
– fullname: RICHARD, DAVID, J
BookMark eNrjYmDJy89L5WQwCQnydIzy9HNVcPb3DfAP9XMJVnAMVggwNFbw9vRzDHZVcPRzUfAN8Q9S8PTz8HTyBLKCeRhY0xJzilN5oTQ3g5yba4izh25qQX58anFBYnJqXmpJfFCwqYW5kYmToTFBBQDJ3Sfk
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate JEDINJENJA TRIAZINA KAO INHIBITORI PI3 KINAZE I MTOR
ExternalDocumentID RS58724B1
GroupedDBID EVB
ID FETCH-epo_espacenet_RS58724B13
IEDL.DBID EVB
IngestDate Fri Jul 19 13:08:28 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Serbian
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_RS58724B13
Notes Application Number: RS2019P000552
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190628&DB=EPODOC&CC=RS&NR=58724B1
ParticipantIDs epo_espacenet_RS58724B1
PublicationCentury 2000
PublicationDate 20190628
PublicationDateYYYYMMDD 2019-06-28
PublicationDate_xml – month: 06
  year: 2019
  text: 20190628
  day: 28
PublicationDecade 2010
PublicationYear 2019
RelatedCompanies WYETH LLC
RelatedCompanies_xml – name: WYETH LLC
Score 3.2191522
Snippet TRIAZINE COMPOUNDS AS PI3 KINASE AND MTOR INHIBITORS Compounds of formula I wherein: R 1 is and R 2 , R 4 , and R 6-9 are defined herein, and pharmaceutically...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title TRIAZINE COMPOUNDS AS P13 KINASE AND MTOR INHIBITORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190628&DB=EPODOC&locale=&CC=RS&NR=58724B1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LS8NAEB5KFfWm9f0oe5DcgqZ5H4LkSSLkQTaV4qV08xAvWpqIf9_ZkKqX3oZdmN0dmJ35ducBcI_-mlRJii5qWimLSqNrIqtrWSzNaoWwmUmPJs93jhMtnCvPC3UxgrdtLkxfJ_S7L46IGlWivnf9fb3-e8Ty-tjK9oG949DnU1BYnjCgY4lX3TUEz7H8LPVSV3BdK6dCkluqoc8UB2HSHveheZF9_8XhKSnr__YkOIb9DFl9dCcwajcTOHS3bdcmcBAPv91IDorXnoJS5JH9GiU-cdM4S-eJR4lNSSbJBPG3TX1iJx6JizQnURJGToQUPYNp4BduKOLyy9-DLnM6bFM-hzGi__oSiGquGk1lcqMZ6LowHeEV761blY1S6ZUuX8HFDibXO2du4IjLikc8zYxbGHebr_oObWvHpr1cfgDwAXmU
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT8MwDLamgRg3GI_xGjmg3iro-kh3qFBfUwtrWrUdmrhM6wtxgWkr4u_jVB1w2c1KJCex5Nhf4gfAHfprUiEpVNS0XBaVimpiVpaymI-LJcLmTHoY83zngGneTHmaq_MOvG1zYZo6od9NcUTUqBz1vW7u69XfI5bTxFZu7rN3HPp8nKSGI7ToWOJVd3XBsQw3Cp3QFmzbiBOBxYaq05FiIUzao4gHeZF998XiKSmr__ZkcgT7EbL6qI-hs1n3oWdv26714SBof7uRbBVvcwJKGvvmq89cYodBFM6YkxAzIZEkE8TfZuISkzkkSMOY-MzzLR-p5BSGEze1PRGXX_wedBEn7TblM-gi-i8HQNTxstLUTK40HV2XjCK84r11i7xSClpQ-QLOdzC53DlzCz0vDaaLqc-er-CQy41HP430a-jW66_yBu1snQ0bGf0AxMJ8fw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=TRIAZINE+COMPOUNDS+AS+P13+KINASE+AND+MTOR+INHIBITORS&rft.inventor=VENKATESAN%2C+ARANAPAKAM%2C+M&rft.inventor=AYRAL-KALOUSTIAN%2C+SEMIRAMIS&rft.inventor=SHI%2C+MENGXIAO&rft.inventor=DELOS+SANTOS%2C+EFREN%2C+GUILLERMO&rft.inventor=GOPALSAMY%2C+ARIAMALA&rft.inventor=CURRAN%2C+KEVIN%2C+J&rft.inventor=DOS+SANTOS%2C+OSVALDO&rft.inventor=MANSOUR%2C+TAREK%2C+S&rft.inventor=DEHNHARDT%2C+CHRISTOPH%2C+M&rft.inventor=KAPLAN%2C+JOSHUA%2C+AARON&rft.inventor=ZASK%2C+ARIE&rft.inventor=CHEN%2C+ZECHENG&rft.inventor=VERHEIJEN%2C+JEROEN%2C+C&rft.inventor=RICHARD%2C+DAVID%2C+J&rft.date=2019-06-28&rft.externalDBID=B1&rft.externalDocID=RS58724B1